Medicare Enrolled
Dr. Fadi Alameddine, M.D.
Nuclear Cardiology Physician · Cypress, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alameddine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alameddine? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alameddine
Dr. Fadi Alameddine is a nuclear cardiology physician in Cypress, TX, with 20 years in practice. Based on federal Medicare data, Dr. Alameddine performed 11,701 Medicare services across 5,888 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alameddine received a total of $16,106 from 57 pharmaceutical and/or device companies across 621 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alameddine is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 4% volume in TX$ $16,106 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,701
Medicare services
Top 4% in TX for nuclear cardiology physician
5,888
Unique beneficiaries
$135
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~585 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 2,954 | $51 | $100 |
| Office visit, established patient (30-39 min) | 1,353 | $98 | $323 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,320 | $42 | $295 |
| Chronic care management, additional 20 min/month | 1,030 | $39 | $75 |
| Electrocardiogram (EKG), 12-lead | 933 | $11 | $37 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 542 | $50 | $100 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 502 | $55 | $182 |
| Echocardiogram, transthoracic | 340 | $142 | $499 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 308 | $642 | $2,366 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 304 | $1,980 | $3,000 |
| Ultrasound of both sides of head and neck blood flow | 279 | $148 | $485 |
| Nuclear medicine study of heart muscle blood flow by pet | 208 | $147 | $1,258 |
| Remote pacemaker monitoring, 90 days | 170 | $24 | $75 |
| Telephone medical discussion with physician, 21-30 minutes | 162 | $86 | $321 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 142 | $208 | $679 |
| Hospital follow-up visit, high complexity | 125 | $94 | $311 |
| New patient office visit (45-59 min) | 123 | $128 | $419 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 119 | $20 | $65 |
| Office visit, established patient, complex (40-54 min) | 89 | $140 | $450 |
| Ultrasound of leg arteries or artery grafts | 88 | $195 | $620 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 87 | $39 | $75 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 73 | $28 | $92 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 71 | $127 | $464 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 66 | $140 | $479 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $10 | $44 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 57 | $638 | $1,558 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 55 | $362 | $1,128 |
| Cardiac catheterization | 42 | $228 | $2,628 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 27 | $225 | $699 |
| Office visit, established patient (20-29 min) | 23 | $72 | $227 |
| Initial hospital admission, high complexity | 18 | $143 | $436 |
| Hospital follow-up visit, moderate complexity | 18 | $65 | $199 |
| New patient office visit, complex (60-74 min) | 14 | $174 | $553 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.9% high complexity
24.1% medium
69.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,106
Total received (2018-2024)
Avg $2,301/year across 7 years
Top 12% in TX for nuclear cardiology physician
57
Companies
621
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,105 (81.4%)
Other
Charitable contributions, space rental, and other categories
$1,920 (11.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,064 (6.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,159
2023$2,793
2022$3,303
2021$2,613
2020$2,148
2019$1,360
2018$1,730
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$2,995
Abbott Laboratories
$2,244
Janssen Pharmaceuticals, Inc
$1,255
Amgen Inc.
$1,178
Medtronic Vascular, Inc.
$1,060
E.R. Squibb & Sons, L.L.C.
$688
Novartis Pharmaceuticals Corporation
$641
Boston Scientific Corporation
$523
SANOFI-AVENTIS U.S. LLC
$485
Merck Sharp & Dohme LLC
$460
AstraZeneca Pharmaceuticals LP
$398
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$315
Esperion Therapeutics, Inc.
$281
ABIOMED
$274
Tactile Systems Technology Inc
$263
Impulse Dynamics (USA) Inc.
$226
Boehringer Ingelheim Pharmaceuticals, Inc.
$202
PFIZER INC.
$199
Amarin Pharma Inc.
$164
Medicure Pharma Inc.
$160
Baxter Healthcare
$155
Edwards Lifesciences Corporation
$152
Lundbeck LLC
$119
BIOTRONIK INC.
$113
Philips North America LLC
$112
ARBOR PHARMACEUTICALS, INC.
$111
Gilead Sciences, Inc.
$88
Medtronic, Inc.
$84
Kestra Medical Technology Services, Inc.
$82
Arbor Pharmaceuticals, Inc.
$81
Inspire Medical Systems, Inc.
$72
ARALEZ PHARMACEUTICALS US INC.
$71
Actelion Pharmaceuticals US, Inc.
$70
Kowa Pharmaceuticals America, Inc.
$68
Philips Electronics North America Corporation
$65
CVRx, Inc.
$64
Allergan Inc.
$54
Azurity Pharmaceuticals, Inc.
$52
Althera Pharmaceuticals LLC
$45
NormaTec Industries, LP
$41
PORTOLA PHARMACEUTICALS, INC.
$35
Lexicon Pharmaceuticals, Inc.
$34
Itamar Medical Inc
$34
ShockWave Medical, Inc
$33
Merck Sharp & Dohme Corporation
$30
Kiniksa Pharmaceuticals International, plc
$28
CashFlow Solutions, LLC
$25
Kiniksa Pharmaceuticals, Ltd.
$24
Astellas Pharma US Inc
$23
Regeneron Healthcare Solutions, Inc.
$19
Preventice Services, LLC
$18
Novo Nordisk Inc
$17
AtriCure, Inc.
$16
Lilly USA, LLC
$16
Janssen Scientific Affairs, LLC
$15
InfoBionic, Inc
$15
Bardy Diagnostics, Inc.
$15
Top 3 companies account for 40.3% of total payments
Associated products mentioned in payments ›
(BH4) IGT Devices Undivided · ASSURITY · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Arcalyst · Assure WCD · Azure · BEVYXXA · BG Mini Plus · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Confirm Rx · Connectivity and Remote care · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · FARXIGA · FLEXITOUCH · Flexitouch Plus · General - Therapies · HAWKONE · HMG-CoA reductase inhibitor. · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · Horizant · IGT_D Systems · INSPIRE · Impella · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · Lympha Press Optimal Plus(US) BT · MITRACLIP · MRI Ready Leads · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · MoMe Kardia · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Percepta · QUADRA ASSURA · QUARTET · Quadra Allure MP RF CRT Pacemkr · Quartet CRT Lead · RESONATE EL ICD VR · Repatha · Resolute · Reveal LINQ · Roszet · SEEQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Telescope · VERQUVO · VIGILANT · Vascepa · VenaCure 1470 Pro · Via · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · WatchPATONE · XARELTO · XIENCE V · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (81%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $138 per 100 Medicare services performed
Geographic Context
Nuclear Cardiology Physicians within 10 mi
4
Per 100K population
0.1
County median income
$73,104
Nearest hospital
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Alameddine is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Alameddine experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Alameddine performed 2,954 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alameddine receive payments from pharmaceutical companies?
Yes. Dr. Alameddine received a total of $16,106 from 57 companies across 621 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alameddine's costs compare to other nuclear cardiology physicians in Cypress?
Dr. Alameddine's average Medicare payment per service is $135. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alameddine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Cardiology Physicians in Cypress
Browse nuclear cardiology physicians in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Cardiology Physicians in TX
Nuclear Cardiology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Cardiology Physicians in TX
Which TX nuclear cardiology physicians receive the most from drug and device companies.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology